Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07152873
PHASE1
A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A
Sponsor: Addpharma Inc.
View on ClinicalTrials.gov
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-117 in healthy subjects.
Official title: An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Safety and the Pharmacokinetics of AD-117 Compared to AD-117A in Healthy Adult Volunteers Under Fed State Conditions
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-12-01
Completion Date
2026-03
Last Updated
2025-12-04
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
AD-117
AD-117 1Tab., Per Oral
DRUG
AD-117A
AD-117A 1Tab., Per Oral
Locations (1)
H Plus Yangji Hospital
Seoul, South Korea